GenMark Diagnostics , Nasdaq: GNMK
Offers a molecular diagnostics testing system to hospitals and labs.
Industry: Health Care
First Day Return: -10.0%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 03/19/2010 |
| Offer Price | $6.00 |
| Price Range $6.00 - $7.00 | |
| Offer Shares (mm) | 4.6 |
| Deal Size ($mm) | $28 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/27/2010 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $28 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Pasadena, CA, United States |
| Founded | 2000 |
| Employees at IPO | 63 |
| Website www.genmarkdx.com | |
GenMark Diagnostics (GNMK) Performance
